A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosisRAGHU, Ganesh; BROWN, Kevin K; BRADFORD, Williamson Z et al.The New England journal of medicine. 2004, Vol 350, Num 2, pp 125-133, issn 0028-4793, 9 p.Article

Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung diseaseMOSS, Richard B; MAYER-HAMBLETT, Nicole; NOTH, Imre et al.Pediatric pulmonology. 2005, Vol 39, Num 3, pp 209-218, issn 8755-6863, 10 p.Article

Effects of interferon-γ 1b on biomarker expression in patients with idiopathic pulmonary fibrosisSTRIETER, Robert M; STARKO, Karen M; ENELOW, Richard I et al.American journal of respiratory and critical care medicine. 2004, Vol 170, Num 2, pp 133-140, issn 1073-449X, 8 p.Article

Analyses of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosisKING, Talmadge E; SAFRIN, Sharon; STARKO, Karen M et al.Chest. 2005, Vol 127, Num 1, pp 171-177, issn 0012-3692, 7 p.Article

The clinical course of patients with idiopathic pulmonary fibrosisMARTINEZ, Fernando J; SAFRIN, Sharon; BROWN, Kevin K et al.Annals of internal medicine. 2005, Vol 142, Num 12, pp 963-967, issn 0003-4819, 5 p., 1Article

High-resolution computed tomography in idiopathic pulmonary fibrosis : Diagnosis and prognosisLYNCH, David A; GODWIN, J. David; WEBB, W. Richard et al.American journal of respiratory and critical care medicine. 2005, Vol 172, Num 4, pp 488-493, issn 1073-449X, 6 p.Article

Linking Drugs to Obscure Illnesses: Lessons from Pure Red Cell Aplasia, Nephrogenic Systemic Fibrosis, and Reye's Syndrome. A Report From the Southern Network on Adverse Reactions (SONAR)BENNETT, Charles L; STARKO, Karen M; XIRASAGAR, Sudha et al.Journal of general internal medicine. 2012, Vol 27, Num 12, pp 1697-1703, issn 0884-8734, 7 p.Article